Seattle Genetics, Inc. (NASDAQ:SGEN) is reporting third quarter financial results on Thursday 25th October 2018, .
According to analysts surveyed by Thomson Reuters, SGEN is expected to report 3Q18 loss of $ 0.27 per share from revenue of $ 166.92 million.
The same period from last year, SGEN reportedly had income of $ 0.34 per share on $ 135.29 million in revenue.
For the full year, analysts anticipate top line of $ 659.86 million, while looking forward to loss of $ 0.75 per share bottom line.
About Seattle Genetics, Inc.
|% Change from 52 Week Low|
|% Change from 52 Week High|